Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Subklewe

Showing results (31-40 of 244) with videos related to

Pageof 25
Sort By:
Deutsche Medizinische Wochenschrift (1946)|July 31, 2020
[COVID-19 from the Perspective of Haematology and Haemostaseology]Karsten Spiekermann, Marion Subklewe, Martin Hildebrandt, et al.
Deutsches Arzteblatt International|December 16, 2015
Immunotherapy in TumorsSebastian Kobold, Peter Duewell, Max Schnurr, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 8, 2026
Mapping the clinical landscape of multifunctional CAR T cells: targets, trends, and synergiesIsabella Elias Yonezawa Ogusuku, Nele Knelangen, Boris Engels, et al.
Deutsche Medizinische Wochenschrift (1946)|July 13, 2021
[Update 2021: COVID-19 from the Perspective of Haematology and Haemostaseology]Karsten Spiekermann, Marion Subklewe, Martin Hildebrandt, et al.
Chinese Medical Journal|February 26, 2026
Split CAR-T cells targeting CD312 and TIM-3 for acute myeloid leukemia to reduce the risk of antigen escapeRui Zhang, Yingshuai Wang, Yifan Zhao, et al.
Deutsche Medizinische Wochenschrift (1946)|September 28, 2019
[Immuno-Oncology Meets Intensive Care Medicine: CAR-T cells]Boris Böll, Jorge Garcia Borrega, Peter Schellongowski, et al.
International Journal of Hematology|October 8, 2008
Epstein-Barr virus-associated B-cell lymphoma secondary to FCD-C therapy in patients with peripheral T-cell lymphomaKatja C Weisel, Eckhart Weidmann, Ioannis Anagnostopoulos, et al.
Current Hematologic Malignancy Reports|May 3, 2021
Chimeric Antigen Receptor-Modified T Cells and T Cell-Engaging Bispecific Antibodies: Different Tools for the Same JobMelanie Schwerdtfeger, Mohamed-Reda Benmebarek, Stefan Endres, et al.
Transplantation|September 29, 2006
Impairment of circulating myeloid dendritic cells in immunosuppressed renal/pancreas transplant recipientsKathrin Sebelin, Antje Schulzki, Peter M Kloetzel, et al.
Leukemia Research|June 25, 2014
Impaired NK cells and increased T regulatory cell numbers during cytotoxic maintenance therapy in AMLFelix S Lichtenegger, Robin Lorenz, Katharina Gellhaus, et al.
Pageof 25

Showing results (31-40 of 244) with videos related to

Sort By:
Pageof 25
Deutsche Medizinische Wochenschrift (1946)|July 31, 2020
[COVID-19 from the Perspective of Haematology and Haemostaseology]Karsten Spiekermann, Marion Subklewe, Martin Hildebrandt, et al.
Deutsches Arzteblatt International|December 16, 2015
Immunotherapy in TumorsSebastian Kobold, Peter Duewell, Max Schnurr, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 8, 2026
Mapping the clinical landscape of multifunctional CAR T cells: targets, trends, and synergiesIsabella Elias Yonezawa Ogusuku, Nele Knelangen, Boris Engels, et al.
Deutsche Medizinische Wochenschrift (1946)|July 13, 2021
[Update 2021: COVID-19 from the Perspective of Haematology and Haemostaseology]Karsten Spiekermann, Marion Subklewe, Martin Hildebrandt, et al.
Chinese Medical Journal|February 26, 2026
Split CAR-T cells targeting CD312 and TIM-3 for acute myeloid leukemia to reduce the risk of antigen escapeRui Zhang, Yingshuai Wang, Yifan Zhao, et al.
Deutsche Medizinische Wochenschrift (1946)|September 28, 2019
[Immuno-Oncology Meets Intensive Care Medicine: CAR-T cells]Boris Böll, Jorge Garcia Borrega, Peter Schellongowski, et al.
International Journal of Hematology|October 8, 2008
Epstein-Barr virus-associated B-cell lymphoma secondary to FCD-C therapy in patients with peripheral T-cell lymphomaKatja C Weisel, Eckhart Weidmann, Ioannis Anagnostopoulos, et al.
Current Hematologic Malignancy Reports|May 3, 2021
Chimeric Antigen Receptor-Modified T Cells and T Cell-Engaging Bispecific Antibodies: Different Tools for the Same JobMelanie Schwerdtfeger, Mohamed-Reda Benmebarek, Stefan Endres, et al.
Transplantation|September 29, 2006
Impairment of circulating myeloid dendritic cells in immunosuppressed renal/pancreas transplant recipientsKathrin Sebelin, Antje Schulzki, Peter M Kloetzel, et al.
Leukemia Research|June 25, 2014
Impaired NK cells and increased T regulatory cell numbers during cytotoxic maintenance therapy in AMLFelix S Lichtenegger, Robin Lorenz, Katharina Gellhaus, et al.
Pageof 25